Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 612, pseudogene (RNU6-612P) is a non-coding RNA pseudogene related to U6 small nuclear RNA (snRNA). U6 snRNA is an essential component of the spliceosome, involved in pre-mRNA splicing[1][3]. However, pseudogenes like RNU6-612P are considered genetically inactive copies, arising from duplication or retrotransposition events, and do not produce functional RNA or protein products[4]. As a pseudogene, RNU6-612P lacks biological activity, is not a therapeutic target, and does not participate in canonical U6 snRNA functions. Although some pseudogenes have regulatory or disease roles, there is no evidence directly linking RNU6-612P to any function or pathology in current scientific literature[4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 612, pseudogene (RNU6-612P).